Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer

Condition:   Breast Cancer Interventions:   Drug: oral vinorelbine;   Drug: Capecitabine;   Drug: Gemcitabine 1250 mg/m²;   Drug: Gemcitabine 1000 mg/m²;   Drug: Paclitaxel;   Drug: Docetaxel Sponsor:   Pierre Fabre Medicament Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials